Inogen Net Worth
Inogen Net Worth Breakdown | INGN |
Inogen Net Worth Analysis
Inogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inogen's net worth analysis. One common approach is to calculate Inogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inogen's net worth. This approach calculates the present value of Inogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inogen's net worth. This involves comparing Inogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Inogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inogen's net worth research are outlined below:
| Inogen Inc generated a negative expected return over the last 90 days | |
| Inogen Inc has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 315.66 M. Net Loss for the year was (102.45 M) with profit before overhead, payroll, taxes, and interest of 153.53 M. | |
| Inogen Inc currently holds about 223.62 M in cash with (3.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 90.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Inogen, Inc. Short Interest Down 11.4 percent in October |
Inogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inogen Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Inogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inogen Inc backward and forwards among themselves. Inogen's institutional investor refers to the entity that pools money to purchase Inogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-06-30 | 548.3 K | State Street Corp | 2024-06-30 | 497 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 484.6 K | Renaissance Technologies Corp | 2024-09-30 | 417.9 K | New York State Common Retirement Fund | 2024-09-30 | 410.3 K | Meros Investment Management, Lp | 2024-06-30 | 397.2 K | Federated Hermes Inc | 2024-09-30 | 346 K | Jacobs Levy Equity Management, Inc. | 2024-06-30 | 310.4 K | Jane Street Group Llc | 2024-06-30 | 301.4 K | Camber Capital Management Llc | 2024-09-30 | 2 M | Blackrock Inc | 2024-06-30 | 1.6 M |
Follow Inogen's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 219.37 M.Market Cap |
|
Project Inogen's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.36) | (0.35) | |
| Return On Capital Employed | (0.43) | (0.41) | |
| Return On Assets | (0.31) | (0.30) | |
| Return On Equity | (0.50) | (0.48) |
When accessing Inogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inogen's profitability and make more informed investment decisions.
Evaluate Inogen's management efficiency
Inogen Inc has return on total asset (ROA) of (0.0966) % which means that it has lost $0.0966 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2533) %, meaning that it created substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to grow to -0.35. In addition to that, Return On Capital Employed is likely to grow to -0.41. At this time, Inogen's Deferred Long Term Asset Charges is very stable compared to the past year. As of the 22nd of November 2024, Intangibles To Total Assets is likely to grow to 0.14, while Total Assets are likely to drop about 292 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.84 | 7.61 | |
| Tangible Book Value Per Share | 6.91 | 6.50 | |
| Enterprise Value Over EBITDA | (0.52) | (0.49) | |
| Price Book Value Ratio | 0.62 | 0.59 | |
| Enterprise Value Multiple | (0.52) | (0.49) | |
| Price Fair Value | 0.62 | 0.59 | |
| Enterprise Value | 23.7 M | 22.5 M |
At Inogen Inc, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 0.3585 | Revenue 331.5 M | Quarterly Revenue Growth 0.058 | Revenue Per Share 14.095 | Return On Equity (0.25) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inogen Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F3 | 24th of July 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Inogen Earnings per Share Projection vs Actual
Inogen Corporate Management
| Nabil Shabshab | Pres CEO | Profile | |
| Vijay Paliwal | Senior Enablement | Profile | |
| Adrien Mithalal | Senior Development | Profile | |
| Agnes Lee | VP Planning | Profile | |
| Philip Corrin | Senior Chain | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.